GI Partners completes acquisition of Clinical Ink
Private investment firm GI Partners has completed the previously announced acquisition of Clinical Ink, a global clinical trial technology company.Headquartered in Horsham, Pennsylvania, Clinical Ink offers data certainty from source to submission during clinical trials. The company’s Lumenis eSource clinical technology is a suite of solutions for capturing and integrating